Ware Olivia C 4
4 · Arcellx, Inc. · Filed Apr 18, 2024
Insider Transaction Report
Form 4
Arcellx, Inc.ACLX
Ware Olivia C
Director
Transactions
- Exercise/Conversion
Common Stock
2024-04-16$7.61/sh+9,402$71,549→ 9,402 total - Sale
Common Stock
2024-04-16$55.36/sh−6,790$375,907→ 2,612 total - Sale
Common Stock
2024-04-16$56.03/sh−2,612$146,353→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2024-04-16−9,402→ 36,806 totalExercise: $7.61Exp: 2032-05-16→ Common Stock (9,402 underlying)
Footnotes (4)
- [F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 15, 2023.
- [F2]Represents the weighted average share price of an aggregate total of 6,790 shares sold in the price range of $54.87 to $55.8699 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 2,612 shares sold in the price range of $55.87 to $56.8699 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option will vest each year following Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "Equity Grant Date" shall mean May 16, 2022.